Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype

Molecular Pharmacology

Volumn 61, Issue 3, 2002, Pages 659-666

  Schenk, Paul W ^a   Boersma, Antonius W M ^a   Brok, Mariël ^a   Burger, Herman ^a   Stoter, Gerrit ^a   Nooter, Kees ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARSENITE SODIUM; BUSULFAN; CADMIUM CHLORIDE; CAMPTOTHECIN; CARBOPLATIN; CISPLATIN; DAUNORUBICIN; DNA; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MERCAPTOPURINE; MITOMYCIN C; MUTAGENIC AGENT; OLIGOMYCIN; OXALIPLATIN; PHOSPHOTRANSFERASE; PLATINUM; PROCARBAZINE; STREPTOZOCIN;

ARTICLE; CELL DEATH; CELL KILLING; CONTROLLED STUDY; CROSS RESISTANCE; DNA REPAIR; DRUG ACCUMULATION; DRUG RESISTANCE; DRUG SENSITIVITY; DRUG TOLERANCE; DRUG TRANSPORT; GENE DISRUPTION; GENE INACTIVATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SACCHAROMYCES CEREVISIAE;

ANTINEOPLASTIC AGENTS; CISPLATIN; DNA; DNA ADDUCTS; DOXORUBICIN; DRUG RESISTANCE; GENE SILENCING; PHENOTYPE; PLATINUM; PROTEIN-SERINE-THREONINE KINASES; SACCHAROMYCES CEREVISIAE;

EID: 0036180524     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.61.3.659     Document Type: Article

References (40)

1. A mutation in the MSH5 gene results in alkylation tolerance
2. Enhanced expression and activity of DNA polymerase β in human ovarian tumor cells: Impact on sensitivity towards antitumor agents
3. A positive selection for mutants lacking orotidine-5′-phosphate decarboxylase activity in yeast: 5-fluoro-orotic acid resistance
4. DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines
5. A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin
6. Large-scale analysis of gene expression, protein localization, and gene disruption in Saccharomyces cerevisiae
7. Cisplatin resistance and DNA repair
8. Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography
9. A constant rate of spontaneous mutation in DNA-based microbes
10. Cisplatin and Adriamycin resistance are associated with MutLα and mismatch repair deficiency in an ovarian tumor cell line
11. 4-methylthymine, or the cisplatin-d(GpG) adduct
12. Dependence on RAD52 and RAD1 for anticancer drug resistance mediated by inactivation of mismatch repair genes
13. Testicular cancer: An oncological success story
14. Screening for modulators of spermine tolerance identifies Sky1, the SR protein kinase of Saccharomyces cerevisiae, as a regulator of polyamine transport and ion homeostasis
15. Mutations in the RNA polymerase II transcription machinery suppress the hyperrecombination mutant hpr1Δ of Saccharomyces cerevisiae
16. Metallothianein-like proteins and cell resistance to cis-dichlorodiammineplatinum(II) in L1210 cells
17. The role of DNA mismatch repair in platinum drug resistance
18. Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft
19. Cdi1, a human G1 and S phase protein phosphatase that associates with Cdk2
20. Microsatellite instability is a favorable prognostic indicator in patients with colorectal cancer receiving chemotherapy
21. A mammalian lysosomal membrane protein confers multidrug resistance upon expression in Saccharomyces cerevisiae
22. Recent insights into platinum drug resistance in cancer
23. Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae
24. The molecular basis of cisplatin sensitivity/resistance
25. Regulation of pleiotropic drug resistance in yeast
26. Human mismatch repair and G*T mismatch binding by hMutSα in vitro is inhibited by Adriamycin, actinomycin D, and nogalamycin
27. The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast
28. Role of determinants of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatin
29. Cellular and molecular determinants of cisplatin resistance
30. 32P-postlabeling assay for the quantification of the major platinum-DNA adducts
31. Specificity of the yeast rev3Δ antimutator and REV3 dependency of the mutator resulting from a defect (rad1Δ) in nucleotide excision repair
32. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line
33. Conservation in budding yeast of a kinase specific for SR splicing factors
34. The Saccharomyces cerevisiae Ku autoantigen homologue affects radiosensitivity only in the absence of homologous recombination
35. Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae
36. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine
37. The role of hMLH1, hMSH3, and hMSH6 defects in cisplatin and oxaliplatin resistance: Correlation with replicative bypass of platinum-DNA adducts
38. Repair of rDNA in Saccharomyces cerevisiae: RAD4-independent strand-specific nucleotide excision repair of RNA polymerase I transcribed genes
39. Conserved SR protein kinase functions in nuclear import and its action is counteracted by arginine methylation in Saccharomyces cerevisiae